{"related:3yacuQscd3AJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa030207","authors":["B Pitt","B Pitt W Remme","B Pitt W Remme F Zannad","B Pitt W Remme F Zannad J Neaton…"],"year":2003,"numCitations":5187,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa030207","citationUrl":"http://scholar.google.com/scholar?cites=8103976891160733407&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:3yacuQscd3AJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8103976891160733407&hl=en&as_sdt=0,5","publication":"Mass Medical Soc","p":1,"exp":1596883650832},{"title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","url":"https://www.nejm.org/doi/full/10.1056/NEJM199909023411001","authors":["B Pitt","B Pitt F Zannad","B Pitt F Zannad WJ Remme","B Pitt F Zannad WJ Remme R Cody…"],"year":1999,"numCitations":9560,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJM199909023411001","citationUrl":"http://scholar.google.com/scholar?cites=13669385340574792393&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yXrkMotps70J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13669385340574792393&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Eplerenone in patients with systolic heart failure and mild symptoms","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1009492","authors":["F Zannad","F Zannad JJV McMurray","F Zannad JJV McMurray H Krum…"],"year":2011,"numCitations":2498,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1009492","citationUrl":"http://scholar.google.com/scholar?cites=17916780558115205629&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:_fEUjf0wpfgJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17916780558115205629&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa032292","authors":["MA Pfeffer","MA Pfeffer JJV McMurray","MA Pfeffer JJV McMurray EJ Velazquez…"],"year":2003,"numCitations":2891,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa032292","citationUrl":"http://scholar.google.com/scholar?cites=7660257847329305760&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:oDT2Je2zTmoJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7660257847329305760&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","url":"https://www.nejm.org/doi/full/10.1056/nejmoa010713","authors":["JN Cohn","JN Cohn G Tognoni"],"year":2001,"numCitations":3787,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa010713","citationUrl":"http://scholar.google.com/scholar?cites=3169061316589449913&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ufK-HnrE-isJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3169061316589449913&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM …","url":"https://www.sciencedirect.com/science/article/pii/S0140673603142833","authors":["JJV McMurray","JJV McMurray J Östergren","JJV McMurray J Östergren K Swedberg","JJV McMurray J Östergren K Swedberg CB Granger…"],"year":2003,"numCitations":2336,"pdf":"http://www.columbiamedicine.org/education/r/Cardiology/CHF/ACE-I%20and%20ARB/CHARM-Added.pdf","citationUrl":"http://scholar.google.com/scholar?cites=2194641306986121445&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:5YhOGKTudB4J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2194641306986121445&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the …","url":"https://www.sciencedirect.com/science/article/pii/S0140673603142845","authors":["CB Granger","CB Granger JJV McMurray","CB Granger JJV McMurray S Yusuf","CB Granger JJV McMurray S Yusuf P Held…"],"year":2003,"numCitations":2065,"pdf":"http://www.columbiamedicine.org/education/r/Cardiology/CHF/ACE-I%20and%20ARB/Charm-Alternative.pdf","citationUrl":"http://scholar.google.com/scholar?cites=4151224602030075224&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:WG3dCsgcnDkJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4151224602030075224&hl=en&as_sdt=0,5","publication":"Elsevier"},{"title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa040135","authors":["DN Juurlink","DN Juurlink MM Mamdani","DN Juurlink MM Mamdani DS Lee…"],"year":2004,"numCitations":1704,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa040135","citationUrl":"http://scholar.google.com/scholar?cites=15883762483778083307&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:69lEvtJ1btwJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15883762483778083307&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular …","url":"https://www.nejm.org/doi/full/10.1056/NEJM199209033271001","authors":["MA Pfeffer","MA Pfeffer E Braunwald","MA Pfeffer E Braunwald LA Moyé…"],"year":1992,"numCitations":6768,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJM199209033271001","citationUrl":"http://scholar.google.com/scholar?cites=14094009670530779516&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:fEnoQB_7l8MJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14094009670530779516&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Effect of carvedilol on survival in severe chronic heart failure","url":"https://www.nejm.org/doi/full/10.1056/NEJM200105313442201","authors":["M Packer","M Packer AJS Coats","M Packer AJS Coats MB Fowler…"],"year":2001,"numCitations":4078,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJM200105313442201","citationUrl":"http://scholar.google.com/scholar?cites=13309555861479713429&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:lWq3-YkKtbgJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13309555861479713429&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"}]}